OBJECTIVES: To evaluate the toxicity of therapeutic sequences High Intensity Focused Ultrasound (HIFU)-salvage radiotherapy (HIFU-RT) or radiotherapy-salvage HIFU (RT-HIFU) in case of locally recurrent prostate cancer.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
MATERIALS AND METHODS: Nineteen patients had a local recurrence of prostate cancer. Among them, 10 patients were treated by HIFU-RT and 9 patients by RT- HIFU (4 by external beam radiotherapy [EBR] and 5 by brachytherapy [BRACHY]). Urinary side effects were assessed using CTCAE v4.
RESULTS: At the time of the initial management, the median age was 66.5 years (53-72), the median PSA was 10.8ng/mL (3.4-50) and the median initial Gleason score was 6.3 (5-8). Median follow-up after salvage treatment was 46.3 months (2-108). Thirty percent of the patients in the HIFU-RT group and 33.3 % of the patients in the RT-HIFU group, all belonging to the sub-group BRACHY-HIFU, had urinary complication greater than or equal to grade 2. Among all the patients, only 1 had grade 1 gastrointestinal toxicity.
CONCLUSION: BRACHY-HIFU sequence seems to be purveyor of many significant urinary side effects. A larger database is needed to confirm this conclusion.
Lee JW, Chevallier D, Gal J, Rouscoff Y, Natale R, Chand ME, Raffaelli C, Ambrosetti D, Durand M, Amiel J, Hannoun-Levi JM. Are you the author?
Département de radiothérapie oncologique, centre Antoine-Lacassagne, université de Nice Sophia Antipolis, 33, avenue de Valombrose, 06189 Nice cedex 2, France; Service d'urologie et de transplantation, hôpital Archet 2, centre hospitalier universitaire de Nice, université de Nice Sophia Antipolis, 151, route de Saint-Antoine, 06202 Nice cedex 3, France; Unité de biostatistiques, centre Antoine-Lacassagne, 33, avenue de Valombrose, 06189 Nice cedex 2, France; Département de radiologie, hôpital Pasteur, centre hospitalier universitaire de Nice, 30, voie Romaine, 06001 Nice cedex 1, France; Laboratoire central d'anatomie pathologique, hôpital Pasteur, centre hospitalier universitaire de Nice, 30, voie Romaine, 06001 Nice cedex 1, France.
Reference: Prog Urol. 2014 Sep 17. pii: S1166-7087(14)00445-X.
Article in French.